MaxCyte, Inc. Cell & Gene Tech Expo August 2025: Cell Therapy

Cell and gene therapies are revolutionizing treatments for cancer and other serious diseases, but immune cell engineering remains difficult due to their sensitivity and resistance to standard transfection. MaxCyte’s ExPERT™ electroporation platform offers a highly efficient, scalable solution for delivering mRNA, DNA, and CRISPR-Cas9 RNPs into hard-to-transfect cells. This talk highlights optimized workflows that streamline cell engineering from discovery to clinical and commercial production.